Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: Results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial

American Journal of Clinical Nutrition

Volumn 93, Issue 3, 2011, Pages 652-665

  Phelan, Niamh ^a   O'Connor, Annalouise ^b   Tun, Tommy Kyaw ^a   Correia, Neuman ^a   Boran, Gerard ^a   Roche, Helen M ^b   Gibney, James ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FATTY ACID BLOOD LEVEL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; METABOLIC REGULATION; NONHUMAN; OVARY POLYCYSTIC DISEASE; RANDOMIZED CONTROLLED TRIAL; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL; THECA CELL;

ADULT; ANDROGENS; ANIMALS; BIOLOGICAL MARKERS; CATTLE; CELLS, CULTURED; COHORT STUDIES; CROSS-OVER STUDIES; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; OVARY; POLYCYSTIC OVARY SYNDROME; POSTPRANDIAL PERIOD; PRINCIPAL COMPONENT ANALYSIS; THECA CELLS; YOUNG ADULT;

BOVINAE;

EID: 79951873619     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.005538     Document Type: Article

References (45)

1. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800. (Pubitemid 28009567)
2. Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF. Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up. Curr Diab Rep 2006;6:77-83.
3. Phelan N, O'Connor A, Kyaw-Tun T, et al. Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS. J Clin Endocrinol Metab 2010;95:3933-9.
4. Berneis K, Rizzo M, Hersberger M, et al. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Int J Clin Pract 2009;63:56-62.
5. Talbott E, Clerici A, Berga SL, et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 1998;51:415-22. (Pubitemid 28223308)
6. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006;65:137-45. (Pubitemid 44079674)
7. Roche HM. Fatty acids and the metabolic syndrome. Proc Nutr Soc 2005;64:23-9. (Pubitemid 40685748)
8. Deckelbaum RJ, Worgall TS, Seo T. n-3 fatty acids and gene expression. Am J Clin Nutr 2006;83:1520S-5S.
9. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not a-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006;84:5-17. (Pubitemid 44699166)
10. Williams CM, Moore F, Morgan L, Wright J. Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. Br J Nutr 1992;68:655-66. (Pubitemid 23027126)
11. Lovegrove JA, Lovegrove SS, Lesauvage SV, et al. Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians. Am J Clin Nutr 2004;79:974-82. (Pubitemid 41095948)
12. Harris WS, Muzio F. Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr 1993;58:68-74. (Pubitemid 23193236)
13. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57. (Pubitemid 35364932)
14. Kobayashi N, Barnard RJ, Henning SM, et al. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 2006;12:4662-70. (Pubitemid 44297819)
15. McEntee MF, Ziegler C, Reel D, et al. Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer. Am J Pathol 2008;173:229-41. (Pubitemid 351947970)
16. Liu J, Shimizu K, Kondo R, et al. Anti-androgenic activity of fatty acids. Chem Biodivers 2009;6:503-12.
17. Kasim-Karakas SE, Almario RU, Gregory L, Wong R, Todd H, Lasley BL. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:615-20. (Pubitemid 38269867)
18. Cussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 2009;94:3842-8.
19. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 2000;83:S91-6.
20. Velázquez ME, Bellabarba GA, Mendoza S, Sanchez L. Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin. Fertil Steril 2000;74:1159-63.
21. Bahceci M, Aydemir M, Tuzcu A. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome. Fertil Steril 2007;87:1363-8. (Pubitemid 46829144)
22. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16. (Pubitemid 47080485)
23. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882-8. (Pubitemid 26301607)
24. O'Connor A, Phelan N, Tun TK, Boran G, Gibney J, Roche HM. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab 2010;95:1378-85.
25. Warensjo E, Sundstrom J, Lind L, Vessby B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 2006;84:442-8. (Pubitemid 44699158)
26. Minihane AM, Khan S, Leigh-Firbank EC, et al. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 2000;20:1990-7. (Pubitemid 30648814)
27. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42. (Pubitemid 13214364)
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. (Pubitemid 15018832)
29. Roche HM, Gibney MJ. Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state. Lipids 1999;34:S259-65.
30. Phillips CM, Goumidi L, Bertrais S, et al. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am J Clin Nutr 2009;90:1665-73.
31. Glister C, Kemp CF, Knight PG, et al. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 2004;127:239-54.
32. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83:1467S-76S.
33. Hornstra G, van Houwelingen AC, Kivits GA, Fischer S, Uedelhoven W. Dietary fish and prostanoid formation in man. Adv Prostaglandin Thromboxane Leukot Res 1991;21A:225-8.
34. Wang X, Walsh LP, Reinhart AJ, Stocco DM. The role of arachidonic acid in steroidogenesis and steroidogenic acute regulatory (StAR) gene and protein expression. J Biol Chem 2000;275:20204-9. (Pubitemid 30441632)
35. Castillo AF, Maciel FC, Castilla R, et al. cAMP increases mitochondrial cholesterol transport through the induction of arachidonic acid release inside this organelle in Leydig cells. FEBS J 2006;273:5011-21. (Pubitemid 44673292)
36. Graham J, Franks S, Bonney RC. In vivo and in vitro effects of gamma-linolenic acid and eicosapentaenoic acid on prostaglandin production and arachidonic acid uptake by human endometrium. Prostaglandins Leukot Essent Fatty Acids 1994;50:321-9.
37. Mai K, Bobbert T, Kullmann V, et al. Free fatty acids increase androgen precursors in vivo. J Clin Endocrinol Metab 2006;91:1501-7.
38. Mai K, Bobbert T, Reinecke F. Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial. J Clin Endocrinol Metab 2008;93:3900-6.
39. Wickenheisser JK, Nelson-Degrave VL, McAllister JM. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1720-7. (Pubitemid 40464044)
40. Wood JR, Nelson VL, Ho C, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 2003;278:26380-90. (Pubitemid 36876777)
41. Cosar E, Ucok K, Akgun L, et al. Body fat composition and distribution in women with polycystic ovary syndrome. Gynecol Endocrinol 2008;24:428-32.
42. Diamanti-Kandarakis E, Paterakis T, Kandarakis HA. Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 2006;1092:175-86. (Pubitemid 47092336)
43. Roche HM, Gibney MJ. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 2000;71:232S-7S.
44. Caslake MJ, Miles EA, Kofler BM. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 2008;88:618-29.
45. Tierney AC, Shaw DI, Gulseth HL, et al. Effects of dietary fat modification on insulin sensitivity and other risk factors of the metabolic syndrome-LIPGENE: an European randomized dietary intervention study. Int J Obes (Epub ahead of print 12 October 2010).